DIANA KORNEEVA: Open Payments
NPI 1295442507 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 51 payments from 17 companies in 2025. Trend: 2023 $1,356 · 2024 $619 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $156 |
| Merck Sharp & Dohme LLC | 6 | $128 |
| Axsome Therapeutics, Inc. | 5 | $122 |
| Amgen Inc. | 4 | $94 |
| Novo Nordisk Inc | 4 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $87 |
| ABBVIE INC. | 4 | $75 |
| PFIZER INC. | 3 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
Products named: IBSRELA, VERQUVO, Symbravo, OTEZLA, XIFAXAN, Ozempic, LEQEMBI, ACCRUFER.
Industry payments across NY — which companies pay providers there.
